Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Breast Cancer: Targets and Therapy Volume 6, 2014 - Issue

Submit an article Journal homepage

Open access

265

Views

CrossRef citations to date

Altmetric

Review

Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer

Drew R Oostra1 Division of Hematology, Oncology, and Transplant. University of Minnesota, Minneapolis, MN, USA

Erin R Macrae2 Division of Medical Oncology, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USACorrespondence[email protected]

Pages 103-113 | Published online: 23 Jul 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (6)

Jingyun Wu, Pianhong Xu & Shinong Zeng. (2022) Trastuzumab therapies in human epidermal growth factor receptor 2 cancer. Highlights in Science, Engineering and Technology 8, pages 32-40.
Crossref

Agampodi Danushi M. Gunasekara, Thunyarat Anothaisintawee, Sitaporn Youngkong, Nguyen T. Ha, Gareth J. McKay, John Attia & Ammarin Thakkinstian. (2022) Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis. Cancers 14:3, pages 523.
Crossref

Meshaal Khan, Ajay V. Maker & Shikha Jain. (2021) The Evolution of Cancer Immunotherapy. Vaccines 9:6, pages 614.
Crossref

Jackie Cheng, Meina Liang, Miguel F. Carvalho, Natalie Tigue, Raffaella Faggioni, Lorin K. Roskos & Inna Vainshtein. (2020) Molecular Mechanism of HER2 Rapid Internalization and Redirected Trafficking Induced by Anti-HER2 Biparatopic Antibody. Antibodies 9:3, pages 49.
Crossref

Kyung-Hee Chun, Jong Hoon Park & Siting Fan. 2017. Translational Research in Breast Cancer. Translational Research in Breast Cancer 59 104 .

Shahid Ahmed, Amer Sami & Jim Xiang. (2015) HER2-directed therapy: current treatment options for HER2-positive breast cancer. Breast Cancer 22:2, pages 101-116.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references